Brief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
11/05/2026 02:42
May 11 (Reuters) - IX Biopharma Ltd IXBI.SI: WILL UNDERTAKE AN INTERNAL RESTRUCTURING OF ITS CONSUMER BUSINESS CO AND GLD IN ADVANCED DISCUSSIONS ON TERMS OF PROPOSED JV THAT WOULD INCORPORATE ORION INTO LIGO STRUCTURE Further company coverage: IXBI.SI ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: Ix Biopharma Confirms Orion Not Yet Obtained Licence From Nevada State Board Of Pharmacy
Brief: Ix Biopharma Says U.S. Govt Opens Emergency Pathway, Clears Path For Wafermine Application For EUA
Brief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine